GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Mmp9 | multiple interactions | EXP | | 6480464 | CTD | [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of MMP9 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride] affects the expression of MMP9 protein | PMID:31332895 | Mmp9 | decreases activity | ISO | MMP9 (Homo sapiens) | 6480464 | CTD | Raloxifene Hydrochloride results in decreased activity of MMP9 protein | PMID:17582780 | Mmp9 | decreases expression | ISO | MMP9 (Homo sapiens) | 6480464 | CTD | Raloxifene Hydrochloride results in decreased expression of MMP9 mRNA | PMID:17582780 | Mmp9 | increases expression | ISO | Mmp9 (Mus musculus) | 6480464 | CTD | Raloxifene Hydrochloride results in increased expression of MMP9 mRNA | PMID:22841776 | |
Go Back to source page | Continue to Ontology report |